• XPO1 Inhibition by Eltanexor Modulates Wnt/β-catenin in CRC

  2026-04-28

  This study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, reduces colorectal cancer (CRC) tumorigenesis by disrupting the Wnt/β-catenin signaling pathway and lowering COX-2 expression. Findings provide mechanistic rationale for XPO1-targeted chemoprevention in high-risk CRC populations, with translational implications for broader cancer research.

• Protease and Phosphatase Inhibitor Cocktail: Mechanistic Ins

  2026-04-28

  Explore the science behind the Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O), revealing its mechanistic advantages for protein extraction and phospho-proteomics. This article offers a unique, evidence-based perspective on optimizing protein preservation in complex biological assays.

• BMP4-GPX4 Axis Reduces Ferroptosis in Glaucoma RGC Models

  2026-04-27

  This study demonstrates that BMP4-driven GPX4 upregulation mitigates ferroptosis and supports retinal ganglion cell survival in a mouse glaucoma model. The findings highlight a mechanistic pathway that enhances the differentiation of transplanted retinal stem cells under high intraocular pressure, suggesting new directions for neuroprotective intervention in glaucoma.

• Applied Workflows for the Caspase-4 Colorimetric Assay Kit

  2026-04-27

  Unlock precise detection of LEVD-dependent caspase-4 activity using the Caspase-4 Colorimetric Assay Kit from APExBIO. This article details stepwise protocols, advanced applications in pyroptosis and organelle-targeted research, and expert troubleshooting tips to drive robust, reproducible results in inflammation and cell fate studies.

• Adipose-Neural Axis in Cardiac Arrhythmias: Mechanistic Insi

  2026-04-26

  Fan et al. (2024) established a stem cell-based coculture model to unravel how the adipose-neural axis—specifically leptin and neuropeptide Y (NPY) signaling—drives epicardial adipose tissue (EAT)-related cardiac arrhythmias. Their mechanistic findings highlight novel intervention targets, providing a robust foundation for translational research on arrhythmogenesis.

• N1-Methyl-Pseudouridine-5'-Triphosphate: RNA Stability & mRN

  2026-04-25

  N1-Methyl-Pseudouridine-5'-Triphosphate (N1-Methylpseudo-UTP) is a modified nucleoside triphosphate that enhances mRNA stability and translational efficiency. This compound is essential for in vitro transcription protocols in advanced mRNA therapeutics and vaccine development, as extensively validated in recent peer-reviewed studies and by the APExBIO product specification.

• Amine Chemistry in Polymer Micelles Drives Lung-Targeted mRN

  2026-04-24

  This study systematically investigates how amine type in polymer micelles determines mRNA binding, delivery efficiency, and tissue selectivity, particularly for lung-targeted applications. Machine learning analysis reveals that fine-tuning amine chemistry is critical for optimizing both in vitro and in vivo mRNA delivery, offering actionable insights for the design of next-generation gene delivery systems.

• Site-Specific vs. Random Biotinylation: Optimizing IL7 Funct

  2026-04-24

  This study introduces a prokaryotic AviTag/BirA platform for site-specific biotinylation of interleukin-7 (IL7), demonstrating minimized loss of cytokine activity compared to conventional chemical (random) biotinylation. The findings offer a robust strategy for producing functional, biotin-labeled proteins, with significant implications for bioactivity preservation in therapeutic and analytical workflows.

• ω-Agatoxin IVA TFA: Precision in Neuronal Calcium Channel As

  2026-04-23

  ω-Agatoxin IVA TFA empowers researchers with nanomolar-specific P/Q-type calcium channel blockade, enabling fine-tuned neuronal current and synaptic transmission studies. Its proven potency and selectivity make it an essential tool for dissecting neurotransmission and neuroprotection in both in vitro and in vivo models.

• AZD2461: Novel PARP Inhibitor for Breast Cancer Research

  2026-04-23

  AZD2461 is a potent, novel PARP inhibitor with a 5 nM IC50, designed to target DNA repair pathways in breast cancer cells. It demonstrates robust cytotoxicity in MCF-7 and SKBR-3 lines, overcomes Pgp-mediated resistance, and extends relapse-free survival in BRCA1-mutated tumor models. These features position AZD2461 as a valuable tool for cancer biology research and translational workflows.

• Biotin-HPDP in Redox-Driven Neurobiology: Mechanism, Protoco

  2026-04-22

  Explore how Biotin-HPDP enables precise thiol-specific protein labeling in advanced neurobiological and redox studies. This article offers a unique analysis bridging molecular mechanisms to practical protocol choices, with deep insights from recent selenoprotein research.

• Metformin Mitigates Choroidal Neovascularization in AMD Mode

  2026-04-22

  This study demonstrates that intravitreal metformin reduces choroidal neovascularization and retinal degeneration in mouse models, highlighting its anti-angiogenic and neuroprotective effects. The research suggests metformin’s potential as a cost-effective adjunct for neovascular AMD management, supported by robust molecular and histological data.

• Caspase-3 Colorimetric Assay Kit: Practical Guide for Apopto

  2026-04-21

  The Caspase-3 Colorimetric Assay Kit provides a streamlined, quantitative method for measuring DEVD-dependent caspase-3 activity, addressing the need for robust apoptosis assays in neurodegeneration and cancer research. This kit is best suited for researchers requiring rapid, colorimetric detection of caspase-3 in cell or tissue lysates, but is not intended for in vivo imaging or for proteases outside the cysteine-dependent aspartate-directed protease family.

• Bradykinin B2 Receptor Modulation of Ileal Peristalsis: Mech

  2026-04-21

  This study establishes that bradykinin B2 receptors inhibit the peristaltic reflex in the guinea pig ileum, a novel contribution to understanding gastrointestinal motility regulation. The findings clarify receptor specificity and delineate pharmacological effects, informing future research on bradykinin signaling and ACE inhibitor implications.

• Redefining cDNA Synthesis for Translational Research Success

  2026-04-20

  Translational researchers face critical challenges converting complex, low-abundance RNA into reliable cDNA for qPCR and advanced molecular applications. This article dissects the mechanistic barriers, strategic solutions, and competitive landscape for reverse transcription, leveraging new evidence and the advanced engineering of APExBIO’s HyperScript™ Reverse Transcriptase. We bridge recent insights from retinal degeneration research with practical workflow guidance, offering a forward-looking perspective for those driving biomedical innovation.

16325 records 1/1089 page Next 12345 下5页 Last page